8 Results
June/July 2008
- 2008 World Stem Cell Summit
- Translational Medicine Approach to Drug Development in Osteoporosis: Thinking Beyond BMD
Daniel S. Johnston1, John A. Robinson2 and Salvatore Alesci1 Wyeth Research 1Discovery Translational Medicine 2Women’s Health & Musculoskeletal Biology, Osteoporosis Research
- IBCs 13th Annual World Congress Drug Discovery and Development of Innovative Therapeutics
- Biomarkers for Alzheimer’s Disease: Translational Medicine Approaches in Development of Disease Modifying Therapeutics: Part 1. Biochemical Biomarkers for Disease-Modifying Therapeutics in Alzheimer’s Disease
Hong I. Wan, Ph.D.1, Mark Day, Ph.D.2, Orest Hurko, M.D. and J. Lynn Rutkowski, Ph.D.3 1Clinical Translational Medicine 2Discovery Translational Research Dept 3University of Dundee Wyeth Pharmaceuticals
- Translational Medicine Perspectives in Drug Discovery and Development Part III: Disease Biomarkers- Setting the Lexicon Straight for Drug Registration, Drug Labeling and Commercial Opportunities
Giora Z. Feuerstein MD, Christina Coughlin MD, PhD, Robert R. Ruffolo Jr. PhD, Charles Dormer, Frank S. Walsh PhD, Orest Hurko MD, 1J. Lynn Rutkowski PhD Wyeth Research 1University of Dundee, UK
- Profiling ‘microRNA’ on a ‘macro’ Scale in Adult Neural Stem Cells
Keith Szulwach and Peng Jin, Ph.D. Department of Human Genetics, Emory University School of Medicine
- Applications of Automation in Cell Supply for Screening – Benefits and Limitations
Alison Rush Department of Automated Biotechnology Merck & Co., Inc.
- High-Throughput Optical Label-Free in Early Drug Discovery: From Biomolecular Interactions to Cellular Phenotypes
Julio Martin, Ph.D. Molecular Discovery Research GlaxoSmithKline